1. Gibbons T, Rieger R. Vizsla Club of America Welfare Foundation 2008 Health Survey. Available at: vcaweb.org/download/Vizsla-Health-Survey-Analysis_Final-V3.pdf. Accessed Apr 19, 2009.
2. Prymak C, McKee LJ, Goldschmidt MH, et al. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 1988; 193: 706–712.
3. Ware WA, Hopper DL. Cardiac tumors in dogs: 1982–1995. J Vet Intern Med 1999; 13: 95–103.
4. Aquilina JW, McKinney L, Pacelli A, et al. High grade prostatic intraepithelial neoplasia in military working dogs with and without prostate cancer. Prostate 1998; 36: 189–193.
5. Bell FW, Klausner JS, Hayden DW, et al. Clinical and pathologic features of prostatic adenocarcinoma in sexually intact and castrated dogs: 31 cases (1970–1987). J Am Vet Med Assoc 1991; 199: 1623–1630.
6. Bryan JN, Keeler MR, Henry CJ, et al. A population study of neutering status as a risk factor for canine prostate cancer. Prostate 2007; 67: 1174–1181.
7. Sorenmo KU, Goldschmidt M, Shofer F, et al. Immunohistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration time. Vet Comp Oncol 2003; 1: 48–56.
8. Teske E, Naan EC, van Dijk EM, et al. Canine prostate carcinoma: epidemiological evidence of an increased risk in castrated dogs. Mol Cell Endocrinol 2002; 197: 251–255.
9. Glickman LT, Raghavan M, Knapp DW, et al. Herbicide exposure and the risk of transitional cell carcinoma of the urinary bladder in Scottish Terriers. J Am Vet Med Assoc 2004; 224: 1290–1297.
10. Norris AM, Laing EJ, Valli VE, et al. Canine bladder and urethral tumors: a retrospective study of 115 cases (1980–1985). J Vet Intern Med 1992; 6: 145–153.
11. Knapp DW, Glickman NW, Denicola DB, et al. Naturally-occurring canine transitional cell carcinoma of the urinary bladder. A relevant model of human invasive bladder cancer. Urol Oncol 2000; 5: 47–59.
12. Cooley DM, Beranek BC, Schlittler DL, et al. Endogenous gonadal hormone exposure and bone sarcoma risk. Cancer Epidemiol Biomarkers Prev 2002; 11: 1434–1440.
13. Priester WA, Mckay FW. The occurrence of tumors in domestic animals. Natl Cancer Inst Monogr 1980; 54: 1–120.
14. Ru G, Terracini B, Glickman LT. Host related risk factors for canine osteosarcoma. Vet J 1998; 156: 31–39.
15. Bamberger M, Houpt KA. Signalment factors, comorbidity, and trends in behavior diagnoses in dogs: 1,644 cases (1991–2001). J Am Vet Med Assoc 2006; 229: 1591–1601.
16. Guy NC, Luescher UA, Dohoo SE, et al. Demographic and aggressive characteristics of dogs in a general veterinary caseload. Appl Anim Behav Sci 2001; 74: 15–28.
17. Kim HH, Yeon SC, Houpt KA, et al. Effects of ovariohysterectomy on reactivity in German Shepherd Dogs. Vet J 2006; 172: 154–159.
18. O'Farrell V, Peachy E. Behavioural effects of ovariohysterectomy on bitches. J Small Anim Pract 1990; 31: 595–598.
19. Reisner IR, Houpt KA, Shofer FS. National survey of owner-directed aggression in English Springer Spaniels. J Am Vet Med Assoc 2005; 227: 1594–1603.
20. Spain CV, Scarlett JM, Houpt KA. Long-term risks and benefits of early-age gonadectomy in dogs. J Am Vet Med Assoc 2004; 224: 380–387.
21. Fleming JM, Creevy KE, Promislow DE. Mortality in North American dogs from 1984 to 2004: an investigation into age-, size-, and breed-related causes of death. J Vet Intern Med 2011; 25: 187–198.
22. Duerr FM, Duncan CG, Savicky RS, et al. Risk factors for excessive tibial plateau angle in large-breed dogs with cranial cruciate ligament disease. J Am Vet Med Assoc 2007; 231: 1688–1691.
23. Duval JM, Budsberg SC, Flo GL, et al. Breed, sex, and body weight as risk factors for rupture of the cranial cruciate ligament in young dogs. J Am Vet Med Assoc 1999; 215: 811–814.
24. Slauterbeck JR, Pankratz K, Xu KT, et al. Canine ovariohysterectomy and orchiectomy increases the prevalence of ACL injury. Clin Orthop Relat Res 2004; 429: 301–305.
25. Whitehair JG, Vasseur PB, Willits NH. Epidemiology of cranial cruciate ligament rupture in dogs. J Am Vet Med Assoc 1993; 203: 1016–1019.
26. van Hagen MA, Ducro BJ, van den Broek J, et al. Incidence, risk factors, and heritability estimates of hind limb lameness caused by hip dysplasia in a birth cohort of Boxers. Am J Vet Res 2005; 66: 307–312.
27. Vidoni B, Sommerfeld-Stur I, Eisenmenger E. Diagnostic and genetic aspects of patellar luxation in small and miniature breed dogs in Austria. Eur J Comp Anim Pract 2005; 16: 149–158.
28. Misdorp W. Canine mammary tumours: effect of late ovariectomy and stimulating effect of progestins. Vet Q 1988; 10: 26–33.
29. Schneider R, Dorn CR, Taylor DO. Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst 1969; 43: 1249–1261.
30. Egenvall A, Hagman R, Bonnett BN, et al. Breed risk of pyometra in insured dogs in Sweden. J Vet Intern Med 2001; 15: 530–538.
31. Fukuda S. Incidence of pyometra in colony-raised Beagle dogs. Exp Anim 2001; 50: 325–329.
32. Hagman R. New aspects of canine pyometra. Acta Vet Scand 2004; 182: 1–55.
33. Misdorp W. Tumors of the mammary gland. In: Meuten DJ, ed. Tumors in domestic animals. 4th ed. Ames, Iowa: Iowa State University Press, 2002;575.
34. Sorenmo KU, Kristiansen VM, Cofone MA, et al. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence. Vet Comp Oncol 2009; 7: 162–172.
35. Sorenmo K. Canine mammary gland tumors. Vet Clin North Am Small Anim Pract 2003; 33: 573–596.
36. Beauvais W, Cardwell JM, Brodbelt DC. The effect of neutering on the risk of mammary tumours in dogs—a systematic review. J Small Anim Pract 2012; 53: 314–322.
37. Sorenmo KU, Rasotto R, Zappulli V, et al. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms. Vet Pathol 2011; 48: 85–97.
38. Torres de la Riva G, Hart BL, Farver TB, et al. Neutering dogs: effects on joint disorders and cancers in Golden Retrievers. PLoS ONE 2013; 8:e55937.
39. Schultheiss PC. A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Invest 2004; 16: 522–526.
40. Muñoz-Cruz S, Togno-Pierce C, Morales-Montor J. Non-reproductive effects of sex steroids: their immunoregulatory role. Curr Top Med Chem 2011; 11: 1714–1727.
41. Calado RT, Yewdell WT, Wilkerson KL, et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 2009; 114: 2236–2243.
42. Colasanti T, Maselli A, Conti F, et al. Autoantibodies to estrogen receptor alpha interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus. Arthritis Rheum 2012; 64: 778–787.
43. Lélu K, Laffont S, Delpy L, et al. Estrogen receptor alpha signaling in T lymphocytes is required for estradiol-mediated inhibition of Th1 and Th17 cell differentiation and protection against experimental autoimmune encephalomyelitis. J Immunol 2011; 187: 2386–2393.
44. Phiel KL, Henderson RA, Adelman SJ, et al. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett 2005; 97: 107–113.
45. Engelmann F, Barron A, Urbanski H, et al. Accelerated immune senescence and reduced response to vaccination in ovariectomized female rhesus macaques. Age (Dordr) 2011; 33: 275–289.
46. Hoffman JM, Creevy KE, Promislow DE. Reproductive capability is associated with lifespan and cause of death in companion dogs. PLoS ONE 2013; 8:e61082.
47. Hopkins SG, Schubert TA, Hart BL. Castration of adult male dogs: effects on roaming, aggression, urine marking, and mounting. J Am Vet Med Assoc 1976; 168: 1108–1110.
48. Neilson JC, Eckstein RA, Hart BL. Effects of castration on problem behaviors in male dogs with reference to age and duration of behavior. J Am Vet Med Assoc 1997; 211: 180–182.
49. Hart BL, Eckstein RA. The role of gonadal hormones in the occurrence of objectionable behaviours in dogs and cats. Appl Anim Behav Sci 1997; 52: 331–344.
50. Serpell J. Measuring behavior and temperament in dogs, in Proceedings. Am Kennel Club Canine Health Found Biennial Nat Parent Club Canine Health Conf 2005;46–48.
51. Patronek GJ, Glickman LT, Beck AM, et al. Risk factors for relinquishment of dogs to an animal shelter. J Am Vet Med Assoc 1996; 209: 572–581.
52. Salman MD, Hutchison JM, Ruch-Gallie R, et al. Behavioral reasons for relinquishment of dogs and cats to 12 shelters. J Appl Anim Welf Sci 2000; 3: 93–106.
53. Mealey KL. Therapeutic implications of the MDR-1 gene. J Vet Pharmacol Ther 2004; 27: 257–264.
Advertisement
Objective—To investigate associations between age at gonadectomy and estimated risk or age at diagnosis of neoplastic and behavioral disorders in Vizslas.
Design—Retrospective cohort study.
Animals—2,505 Vizslas born between 1992 and 2008.
Procedures—Data on demographics, gonadectomy status, and age at diagnosis of disease or disorder were obtained with an anonymous online survey and analyzed.
Results—Dogs gonadectomized at ≤ 6 months, between 7 and 12 months, or at > 12 months of age had significantly increased odds of developing mast cell cancer, lymphoma, all other cancers, all cancers combined, and fear of storms, compared with the odds for sexually intact dogs. Females gonadectomized at ≤ 12 months of age and males and females gonadectomized at > 12 months of age had significantly increased odds of developing hemangiosarcoma, compared with the odds for sexually intact dogs. Dogs gonadectomized at ≤ 6 months of age had significantly increased odds of developing a behavioral disorder. The younger the age at gonadectomy, the earlier the mean age at diagnosis of mast cell cancer, cancers other than mast cell, hemangiosarcoma, lymphoma, all cancers combined, a behavioral disorder, or fear of storms.
Conclusions and Clinical Relevance—Additional studies are needed on the biological effects of removing gonadal hormones and on methods to render dogs infertile that do not involve gonadectomy. Veterinarians should discuss the benefits and possible adverse effects of gonadectomy with clients, giving consideration to the breed of dog, the owner's circumstances, and the anticipated use of the dog.
Ms. Ruffini's present address is Department of Psychology, Binghamton University, State University of New York, Binghamton, NY 13902. Mr. Gibbons' present address is Bogier Clinical and IT Solutions, 900 Ridgefield Dr, Raleigh, NC 27609.
Supported by the Vizsla Club of America Welfare Foundation.
The authors thank Dr. Noah Cohen, Dr. Gayle Watkins, and Chris Bartizal for technical assistance.